1. Li, Guannan, Chen, Hanqing, Shen, Feng, Musi, Nicolas, Zang, Mengwei. 2023. Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesis. In Hepatology (Baltimore, Md.), 78, 1506-1524. doi:10.1097/HEP.0000000000000433. https://pubmed.ncbi.nlm.nih.gov/37129868/
2. Wang, Jian, Wu, Hai-Feng, Shen, Wei, Tao, Guo-Qing, Lu, Pei-Hua. 2016. SRPK2 promotes the growth and migration of the colon cancer cells. In Gene, 586, 41-7. doi:10.1016/j.gene.2016.03.051. https://pubmed.ncbi.nlm.nih.gov/27041240/
3. Wu, Yangjun, Wang, Jiajia, Zhao, Jingjing, He, Xianghuo, Liang, Linhui. 2024. LTR retrotransposon-derived LncRNA LINC01446 promotes hepatocellular carcinoma progression and angiogenesis by regulating the SRPK2/SRSF1/VEGF axis. In Cancer letters, 598, 217088. doi:10.1016/j.canlet.2024.217088. https://pubmed.ncbi.nlm.nih.gov/38945203/
4. Li, Xin, Yang, Shaoyu, Zhang, Minna, Xie, Shuhuan, Xie, Zefeng. 2019. Downregulation of SRPK2 promotes cell cycle arrest though E2F1 in non-small cell lung cancer. In European journal of histochemistry : EJH, 63, . doi:10.4081/ejh.2019.3067. https://pubmed.ncbi.nlm.nih.gov/31833327/
5. Prattapong, Pongphol, Ngernsombat, Chawalit, Aimjongjun, Sathid, Janvilisri, Tavan. 2019. CRISPR/Cas9-mediated double knockout of SRPK1 and SRPK2 in a nasopharyngeal carcinoma cell line. In Cancer reports (Hoboken, N.J.), 3, e1224. doi:10.1002/cnr2.1224. https://pubmed.ncbi.nlm.nih.gov/32671994/
6. Radhakrishnan, Aneesha, Nanjappa, Vishalakshi, Raja, Remya, Gowda, Harsha, Chatterjee, Aditi. 2016. Dysregulation of splicing proteins in head and neck squamous cell carcinoma. In Cancer biology & therapy, 17, 219-29. doi:10.1080/15384047.2016.1139234. https://pubmed.ncbi.nlm.nih.gov/26853621/
智鼠故事 
